CAS 329773-35-5 appears in our catalog under these names: Cinaciguat, Cinaciguat/ 99.82% (existing batch purity), Cinaciguat 98%, 4-[[(4-Carboxybutyl)[2-[2-[[4-(2-phenylethyl)phenyl]methoxy]phenyl]ethyl]amino]methyl]benzoic acid, 98%, 98%, Cinaciguat, 99.15%. Offered by: GLPBio, TargetMol, Biosynth, Ambeed, Chemat. Available pack sizes: 5mg, 1mg, 2mg, 10mg, 25mg, 50mg, 100mg, 500mg.
Cinaciguat is a benzoic acid that is 4-(aminomethyl)benzoic acid in which the amino group is substituted by 4-carboxybutyl and 2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl groups. It is a soluble guanylate cyclase activator, used for the treatment of acute decompensated heart failure. It has a role as a vasodilator agent, an antihypertensive agent and a soluble guanylate cyclase activator. It is a member of benzoic acids, an aromatic ether, a dicarboxylic acid and a tertiary amino compound.
Source: ChEBI
| Molecular formula | C36H39NO5 |
|---|---|
| Molecular weight | 565.7 g/mol |
| IUPAC name | 4-[[4-carboxybutyl-[2-[2-[[4-(2-phenylethyl)phenyl]methoxy]phenyl]ethyl]amino]methyl]benzoic acid |
| InChIKey | WPYWMXNXEZFMAK-UHFFFAOYSA-N |
| SMILES | C1=CC=C(C=C1)CCC2=CC=C(C=C2)COC3=CC=CC=C3CCN(CCCCC(=O)O)CC4=CC=C(C=C4)C(=O)O |
Computed by PubChem (NCBI)